TGFBR3, a receptor for TGF‐β, is implicated in various cancers, including breast cancer, melanoma, prostate cancer, pancreatic cancer, colon cancer, multiple myeloma, neuroblastoma, ovarian cancer, endometrial cancer, and lung cancer.34, 35, 36, 37, 38. This evidence concerns the gene TGFB1 and colonic neoplasm.